Gilead vaccine

The Desire To Find The Covid19 Vaccine Falls Into The Trap Of High Expectations: Gilead’ Trials Fail

There has been a setback in the progress of a treatment to cure Covid-19. It was learned that remdesivir (Gilead’s antiviral) had not shown sufficient clinical improvement in the first clinical trial and even had important side effects. According to the company, these conclusions are associated with the trial that had to be stopped in China due to a lack of patients.